OncoSec Medical: Down on discounted stock offering

OncoSec Medical Incorporated

17/08/2020 13:44

** Shares of immunotherapy developer  ONCS.O  fall 10.3% to
$3.5 premarket; among top pct losers across U.S. indexes
    ** Co prices ~4.6 mln shares of its common stock at
$3.25/shr  urn:newsml:reuters.com:*:nPn3WT9VNa
    ** Offered price is at 16.7% discount to stock's last close
    ** ONCS has 23.03 mln shares outstanding as of Aug. 14 -
Refintiv IBES
    ** Expects gross proceeds of ~$15 mln; intends to use net
proceeds to develop, make and sell its product candidates
    ** Stock gained 115.5% YTD

 (Reporting by Trisha Roy in Bengaluru)
 ((Trisha.Roy@thomsonreuters.com; within U.S. +1 646 223 8780,
outside U.S. +91 80 6182 3635;))